Fig. 5: MBNL2 overexpression attenuates the metastatic ability of breast cancer in vivo.

a Representative examples of lungs from each group (n = 6) after 2 months. b Quantitative analysis of metastatic nodes in the lung. c, d Body weight and lung weight analysis after injected throughout the entire experiments. e HE & immunohistochemistry staining of MBNL2 in lung tissues. Data are presented as mean ± S.D. *P < 0.05, **P < 0.01